We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

293 hedge funds and large institutions have $5.77B invested in Roivant Sciences in 2024 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 102 increasing their positions, 83 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 26

23% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 83

13% more funds holding

Funds holding: 259 → 293 (+34)

7.91% more ownership

Funds ownership: 65.97% → 73.88% (+7.9%)

3% more capital invested

Capital invested by funds: $5.6B → $5.77B (+$165M)

0% more funds holding in top 10

Funds holding in top 10: 19 → 19 (0)

12% less call options, than puts

Call options by funds: $14.4M | Put options by funds: $16.4M

Holders
293
Holders Change
+34
Holders Change %
+13.13%
% of All Funds
4.23%
Holding in Top 10
19
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.27%
New
64
Increased
102
Reduced
83
Closed
26
Calls
$14.4M
Puts
$16.4M
Net Calls
-$2.01M
Net Calls Change
+$472K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$123M
2
Invesco
Invesco
Georgia
+$59.2M
3
RCMNY
Rubric Capital Management (New York)
New York
+$32.9M
4
TCA
Troluce Capital Advisors
Puerto Rico
+$32.3M
5
Goldman Sachs
Goldman Sachs
New York
+$29.6M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$69.1M
2
BBA
Baker Bros. Advisors
New York
-$50.6M
3
ACA
Avoro Capital Advisors
New York
-$49M
4
WP
Woodline Partners
California
-$34.8M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$27.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RTL
276
Red Tortoise LLC
Georgia
$2.55K – – –
UB
277
UMB Bank
Missouri
$2.39K +$2.48K +226 New
QC
278
Quent Capital
New York
$2.11K +$460 +42 +27%
Jones Financial Companies
279
Jones Financial Companies
Missouri
$2.11K +$2.19K +200 New
TSMHT
280
Thurston Springer Miller Herd & Titak
Indiana
$2.11K +$2.19K +200 New
PFBT
281
Parkside Financial Bank & Trust
Missouri
$2.06K – – –
SAM
282
Smartleaf Asset Management
Massachusetts
$1.97K +$2.04K +186 New
TFA
283
Toth Financial Advisory
Virginia
$1.59K – – –
AssetMark Inc
284
AssetMark Inc
California
$1.46K +$1.51K +138 New
FMII
285
Farmers & Merchants Investments Inc
Nebraska
$1.37K +$1.43K +130 New
CIBC Private Wealth Group
286
CIBC Private Wealth Group
Georgia
$1.07K – – –
GWM
287
Geneos Wealth Management
Colorado
$1.06K – – –
Nisa Investment Advisors
288
Nisa Investment Advisors
Missouri
$793 +$822 +75 New
IA
289
IFP Advisors
Florida
$476 +$493 +45 New
HNB
290
Huntington National Bank
Ohio
$433 +$449 +41 New
MCM
291
MV Capital Management
Maryland
$74 +$77 +7 New
TFM
292
TFC Financial Management
Massachusetts
$22 +$22 +2 New
ACA
293
Avoro Capital Advisors
New York
– -$49M -4,651,162 Closed
PCM
294
Philosophy Capital Management
California
– -$13M -1,230,000 Closed
Assenagon Asset Management
295
Assenagon Asset Management
Luxembourg
– -$10.7M -1,018,899 Closed
Renaissance Technologies
296
Renaissance Technologies
New York
– -$10.6M -1,008,600 Closed
SCM
297
Superstring Capital Management
New York
– -$5.6M -531,019 Closed
ACP
298
Altitude Crest Partners
Connecticut
– -$4.79M -454,766 Closed
AIG
299
American International Group
New York
– -$4.74M -450,065 Closed
Connor, Clark & Lunn Investment Management (CC&L)
300
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$3.93M -372,556 Closed
9 10 11
12
13

ROIV Hedge Fund Activity: Q2 2024 in Review

293 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2024, worth a combined $5.77B — up 2.9% from $5.6B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new ROIV positions and 26 closed out — a net gain of 38 holders — while 102 added to existing stakes and 83 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $123M. The largest seller was Morgan Stanley, cutting an estimated $69.1M.

  • 293 institutional investors held Roivant Sciences (ROIV) as of Q2 2024, up from 259 in Q1 2024.
  • Funds reported $5.77B of Roivant Sciences stock for Q2 2024, up 2.9% quarter-over-quarter.
  • 64 funds opened new Roivant Sciences positions in Q2 2024 and 26 closed out, a net change of +38 holders.
  • The largest Roivant Sciences buyer in Q2 2024 was Fidelity Investments, an estimated $123M added.
  • The largest Roivant Sciences seller in Q2 2024 was Morgan Stanley, an estimated $69.1M sold.

Based on aggregated 13F filings for Q2 2024.